Home Other Building Blocks 439083-90-6
439083-90-6,MFCD08702694
Catalog No.:AA00D7VW

439083-90-6 | Bay 60-7550

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$133.00   $93.00
- +
5mg
≥95%
in stock  
$346.00   $242.00
- +
10mg
≥95%
in stock  
$625.00   $437.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00D7VW
Chemical Name:
Bay 60-7550
CAS Number:
439083-90-6
Molecular Formula:
C27H32N4O4
Molecular Weight:
476.5674
MDL Number:
MFCD08702694
SMILES:
COc1cc(ccc1OC)Cc1nn2c(nc(c2c(=O)[nH]1)C)[C@H]([C@H](O)C)CCCc1ccccc1
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
728  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
10  
XLogP3:
4.2  

Literature

Title: Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.

Journal: Psychopharmacology 20160201

Title: Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.

Journal: Circulation 20140805

Title: Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.

Journal: Anesthesiology 20140801

Title: X-ray crystal structure of phosphodiesterase 2 in complex with a highly selective, nanomolar inhibitor reveals a binding-induced pocket important for selectivity.

Journal: Journal of the American Chemical Society 20130814

Title: Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.

Journal: The international journal of neuropsychopharmacology 20130501

Title: Phosphodiesterase 2 inhibitors promote axonal outgrowth in organotypic slice co-cultures.

Journal: Neuro-Signals 20130101

Title: Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801.

Journal: Behavioural brain research 20130101

Title: Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMP.

Journal: American journal of physiology. Renal physiology 20120915

Title: Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.

Journal: Hypertension (Dallas, Tex. : 1979) 20120601

Title: PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.

Journal: Basic research in cardiology 20100501

Title: Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.

Journal: The Journal of pharmacology and experimental therapeutics 20091101

Title: A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.

Journal: Molecular pharmaceutics 20090101

Title: Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.

Journal: European journal of pharmacology 20081214

Title: ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.

Journal: Journal of chemical neuroanatomy 20060601

Title: Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.

Journal: Neuropharmacology 20041201

Title: Masood A, et al. Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling. J Pharmacol Exp Ther. 2009 Nov;331(2):690-9.

Title: Bubb KJ, et al. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension. Circulation. 2014 Aug 5;130(6):496-507.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 439083-90-6
Tags:439083-90-6 Molecular Formula|439083-90-6 MDL|439083-90-6 SMILES|439083-90-6 Bay 60-7550